Roivant Sciences ^Investors

Roivant Sciences is a venture capital fund based in New York, New York, founded in 2014 The firm specializes in the development and commercialization of innovative therapies across various therapeutic areas With an investment scale of approximately $611 million, Roivant aims to accelerate the delivery of new medicines to patients in need The organization is committed to leveraging technology and strategic partnerships to enhance the efficiency of drug development processes Roivant Sciences continues to play a significant role in advancing healthcare solutions through its focused investment strategy